Skip to main content
. 2016 May 12;13(6):418–423. doi: 10.7150/ijms.15519

Figure 2.

Figure 2

Treatment protocol of daclatasvir (DCV) plus asunaprevir (ASV) for real-world HCV genotype 1-infected patients in Japan.